Researcher
Bart Loeys
- Keywords:Medicine
- Disciplines:Cardiac and vascular medicine, Diagnostics, Molecular and cell biology, Physiology, Other clinical sciences, Other medical and health sciences, Developmental genetics, Genetics, Clinical genetics and molecular diagnostics
Affiliations
- Medical Genetics (MEDGEN) (Research group)
Responsible
From1 Oct 2022 → Today - Medical Genetics (MEDGEN) (Research group)
Responsible
From1 Jan 2022 → 30 Sep 2022 - Medical Genetics (MEDGEN) (Research group)
Member
From1 Dec 2010 → 31 Dec 2021
Projects
31 - 40 of 64
- In search of genetic modifiers for aortopathy in Loeys-Dietz families with a SMAD3 mutation.From1 Nov 2019 → 31 Oct 2020Funding: BOF - doctoral mandates
- Elucidating the pathogenicity of genetic variants of uncertain significance in Brugada syndrome patients by functional modelling in hiPSC-derived cardiomyocytes and zebrafish.From1 Nov 2019 → 31 Oct 2020Funding: BOF - doctoral mandates
- Discovery of genetic modifiers of the phenotypical cardiovascular variability in Marfan syndrome to pave the road to individualized treatment protocols.From1 Nov 2019 → TodayFunding: FWO Strategic Basic Research Grant
- Unravelling the discriminative pathomechanisms for biglycan-related aortopathy and spondylo-epi-metaphyseal dysplasia.From1 Oct 2019 → 30 Sep 2022Funding: FWO junior postdoctoral fellowship
- GENOmics in MEDicine: From whole genome sequencing towards personalized medicine (GENOMED).From3 Jul 2019 → TodayFunding: BOF - Methusalem, Fund Recuperation Fiscal Exemption
- Functional assessment and therapeutic targeting of a novel aortapathy syndrome with the strong potential to inform the pathogenesis and treatment of Marfan syndrome.From1 Jul 2019 → 30 Jun 2022Funding: Foreign foundations, funds with scientific view
- Genomic Modifiers of Inherited Aortapathy (Genomia).From1 Jan 2019 → 31 Dec 2023Funding: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
- Functional assessment and therapeutic targeting of a novel aortopathy syndrome caused by resessive IPO8 mutations.From1 Jan 2019 → 31 Dec 2022Funding: FWO Strategic Basic Research Grant
- Optical mapping of in vivo cardiac mechanics in zebrafish: exploring the pathogenesis and mode of inheritance in catecholaminergic polymorphic ventricular tachycardia.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- Unravelling the discriminative pathomechanisms for biglycan-related aortopathy and spondylo-epi-metaphyseal dysplasia.From1 Oct 2018 → 30 Sep 2019Funding: BOF - Other initiatives
Publications
1 - 10 of 253
- Flemish network on rare connective tissue diseases (CTD)(2024)
Authors: Y. Piette, F. van den Bossche, J. Aerts, N. Aerts, S. Ajeganova, V. Badot, N. Berghen, D. Blockmans, G. Brusselle, N. Caeyers, et al.
Pages: 26 - 33 - Homozygous SMAD6 variants in two unrelated patients with craniosynostosis and radioulnar synostosis(2024)
Authors: Ilse Luyckx, Isaac Scott Walton, Nele Boeckx, Kristof Van Schil, Chingyiu Pang, Helen Lord, Christopher Mark Watson, David T. Bonthron, Lut Van Laer, Andrew O.M. Wilkie, et al.
Pages: 1 - 6 - Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome(2024)
Authors: Josephina Meester, Anne Hebert, Maaike Bastiaansen, Laura Rabaut, Jarl Bastianen, Nele Boeckx, Kathryn Ashcroft, Paldeep S. Atwal, Antoine Benichou, Clarisse Billon, et al.
Pages: 1 - 9 - Decoding the genetic puzzle of inherited cardiac arrhythmias(2024)
Authors: Eline Simons, Maaike Alaerts, Bart Loeys, Dorien Schepers
Number of pages: 201 - 2023 ESC Guidelines for the management of cardiomyopathies Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)(2023)
Authors: Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, Eloisa Arbustini, Roberto Barriales-Villa, Cristina Basso, Connie R. Bezzina, Elena Biagini, Nico A. Blom, Rudolf A. de Boer, et al.
Pages: 3503 - 3626 - Structural genomic variants in thoracic aortic disease(2023)
Authors: Josephina Meester, Anne Hebert, Bart Loeys
Pages: 157 - 161 - Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population(2023)
Authors: Ewa Sieliwonczyk, Maaike Alaerts, Eline Simons, Dirk Snyders, Aleksandra Nijak, Bert Vandendriessche, Dorien Schepers, Dogan Akdeniz, Emeline Van Craenenbroeck, Katleen Knaepen, et al.
Pages: 1 - 12 - Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier(2023)
Authors: Melanie Perik, Emmanuela Govaerts, Steven Laga, Inge Goovaerts, Johan Saenen, Emeline Van Craenenbroeck, Josephina Meester, Ilse Luyckx, Inez Rodrigus, Aline Verstraeten, et al.
Pages: 1 - 7 - Growth charts for Marfan syndrome in the Netherlands and analysis of genotype-phenotype relationships(2023)
Authors: Peter Lauffer, Gerard Pals, Aeilko H. Zwinderman, Floor A.M. Postema, Marieke J.H. Baars, Eelco Dulfer, Yvonne Hilhorst-Hofstee, Arjan C. Houweling, Marlies Kempers, Ingrid P.C. Krapels, et al.
Pages: 479 - 489 - Toward reporting standards for the pathogenicity of variant combinations involved in multilocus/oligogenic diseases(2023)
Authors: Sofia Papadimitriou, Barbara Gravel, Charlotte Nachtegael, Elfride De Baere, Bart Loeys, Miikka Vikkula, Guillaume Smits, Tom Lenaerts
Pages: 1 - 11